查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1966062

全球合約研究組織（CRO）市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Contract Research Organization Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 153 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計合約研究組織 (CRO) 市場將從 2025 年的 962.5 億美元成長到 2034 年的 2,022.4 億美元，2026 年至 2034 年的複合年成長率為 8.6%。

受製藥和生物技術研發活動日益活躍的推動，全球合約研究組織 (CRO) 市場正迅速擴張。藥物研發的複雜性不斷增加，監管要求也日益嚴格，促使企業將臨床試驗和實驗室服務外包。 CRO 提供經濟高效且擴充性的解決方案，幫助申辦方在確保合規性的同時加快研發進度。生物製藥、生物相似藥和個人化醫療的蓬勃發展進一步強化了對專業研究能力的需求。新興市場也因其多元化的患者群體和具有競爭力的營運成本，正成為極具吸引力的臨床試驗地點。

關鍵促進因素包括研發支出激增、慢性病盛行率上升以及對高效試驗管理的需求。製藥公司正在擴大與合約研究組織 (CRO) 的策略合作，以最佳化資源配置並降低資本支出。分散式試驗、電子數據採集和人工智慧分析等技術創新正在提高營運效率。此外，各地區監管協調的進展正在促進跨境臨床研究，為全球 CRO服務供應商拓展市場機會。

隨著精準醫療、細胞和基因療法以及罕見疾病研究的拓展，未來前景依然光明。涵蓋臨床前到上市後階段的綜合服務模式的需求預計將會成長。數位健康工具和遠端監測解決方案有望重塑臨床試驗方法。在競爭日益激烈的背景下，專注於治療領域專業知識、先進數據管理以及開拓新興市場的合約研究組織（CRO）將更有利於實現永續的長期成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球合約研究組織 (CRO) 市場：按類型分類

  • 市場分析、洞察與預測
  • 早期開發服務（化學、製造、品管（CMC）、非臨床試驗服務、藥物發現）
  • 臨床試驗（1期、2期、3期、4期）
  • 實驗室服務
  • 其他

第5章：全球合約研究組織 (CRO) 市場：按應用分類

  • 市場分析、洞察與預測
  • 腫瘤學
  • 神經病學
  • 心臟病學
  • 感染疾病
  • 代謝性疾病
  • 腎臟病學/腎臟病學
  • 其他

第6章：全球合約研究組織（CRO）市場：依最終使用者分類

  • 市場分析、洞察與預測
  • 製藥和生物技術公司
  • 醫療設備製造商
  • 學術研究機構
  • 其他

第7章 全球合約研究組織 (CRO) 市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Medpace
    • Laboratory Corporation Of America Holdings
    • ICON Plc
    • IQVIA Inc
    • Syneos Health
    • Novotech
    • KCR SA
    • Ergomed Group
    • Thermo Fisher Scientific Inc
    • WuXi Biologics
    • Tigermed
    • Worldwide Clinical Trials
    • Charles River Laboratories
    • Microbiologics
    • Parexel International（MA）Corporation
簡介目錄
Product Code: VMR11210235

The Contract Research Organization Market size is expected to reach USD 202.24 Billion in 2034 from USD 96.25 Billion (2025) growing at a CAGR of 8.6% during 2026-2034.

The Global Contract Research Organization (CRO) Market has expanded rapidly alongside rising pharmaceutical and biotechnology research activities. Increasing drug development complexity and stringent regulatory requirements have encouraged companies to outsource clinical trials and laboratory services. CROs provide cost-effective, scalable solutions that help sponsors accelerate timelines and maintain compliance. Growth in biologics, biosimilars, and personalized medicine has further strengthened demand for specialized research expertise. Emerging markets have also become attractive destinations for clinical trials due to diverse patient pools and competitive operational costs.

Key drivers include the surge in R&D spending, growing prevalence of chronic diseases, and the need for efficient trial management. Pharmaceutical firms increasingly adopt strategic partnerships with CROs to optimize resources and reduce capital expenditure. Technological advancements such as decentralized trials, electronic data capture, and AI-powered analytics enhance operational efficiency. Additionally, regulatory harmonization across regions has facilitated cross-border clinical studies, broadening market opportunities for global CRO service providers.

Future prospects remain promising as precision medicine, cell and gene therapies, and rare disease research expand. Demand for integrated service models covering preclinical to post-marketing phases is expected to rise. Digital health tools and remote monitoring solutions will likely reshape trial methodologies. As competition intensifies, CROs focusing on therapeutic specialization, advanced data management, and emerging market penetration are well-positioned to achieve sustained long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

  • Early Phase Development Services (Chemistry, Manufacturing, and Controls (CMC), Preclinical Service, Discovery)
  • Clinical (Phase 1, Phase 2, Phase 3, Phase 4)
  • Laboratory Service
  • Others

By Application

  • Oncology
  • Neurology
  • Cardiology
  • Infectious Disease
  • Metabolic Disorder
  • Renal/Nephrology
  • Others

By End-user

  • Pharmaceutical & Biotechnological Companies
  • Medical Device Companies
  • Academic & Research Institutes
  • Others

COMPANIES PROFILED

  • Medpace, Laboratory Corporation of America Holdings, ICON plc, IQVIA Inc, Syneos Health, Novotech, KCR SA, Ergomed Group, Thermo Fisher Scientific Inc, WuXi Biologics, Tigermed, Worldwide Clinical Trials, Charles River Laboratories, Microbiologics, Parexel International MA Corporation

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET: BY TYPE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Type
  • 4.2. Early Phase Development Services (Chemistry, Manufacturing, and Controls (CMC), Preclinical Service, Discovery) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Clinical (Phase 1, Phase 2, Phase 3, Phase 4) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Laboratory Service Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Infectious Disease Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Metabolic Disorder Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Renal/Nephrology Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.8. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Pharmaceutical & Biotechnological Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Medical Device Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CONTRACT RESEARCH ORGANIZATION MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Type
    • 7.2.2 By Application
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Type
    • 7.3.2 By Application
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Type
    • 7.4.2 By Application
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Type
    • 7.5.2 By Application
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Type
    • 7.6.2 By Application
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CONTRACT RESEARCH ORGANIZATION INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Medpace
    • 9.2.2 Laboratory Corporation Of America Holdings
    • 9.2.3 ICON Plc
    • 9.2.4 IQVIA Inc
    • 9.2.5 Syneos Health
    • 9.2.6 Novotech
    • 9.2.7 KCR S.A
    • 9.2.8 Ergomed Group
    • 9.2.9 Thermo Fisher Scientific Inc
    • 9.2.10 WuXi Biologics
    • 9.2.11 Tigermed
    • 9.2.12 Worldwide Clinical Trials
    • 9.2.13 Charles River Laboratories
    • 9.2.14 Microbiologics
    • 9.2.15 Parexel International (MA) Corporation